Abstract

BackgroundWerner syndrome (WS) results from defects in the RecQ helicase (WRN) and is characterized by premature aging and accelerated tumorigenesis. Contradictorily, WRN deficient human fibroblasts derived from WS patients show a characteristically slower cell proliferation rate, as do primary fibroblasts and human cancer cell lines with WRN depletion. Previous studies reported that WRN silencing in combination with deficiency in other genes led to significantly accelerated cellular proliferation and tumorigenesis. The aim of the present study was to examine the effects of silencing WRN in p53 deficient HL60 and p53 wild-type TK6 hematopoietic cells, in order to further the understanding of WRN-associated tumorigenesis.Methodology/Principal FindingsWe found that silencing WRN accelerated the proliferation of HL60 cells and decreased the cell growth rate of TK6 cells. Loss of WRN increased DNA damage in both cell types as measured by COMET assay, but elicited different responses in each cell line. In HL60 cells, but not in TK6 cells, the loss of WRN led to significant increases in levels of phosphorylated RB and numbers of cells progressing from G1 phase to S phase as shown by cell cycle analysis. Moreover, WRN depletion in HL60 cells led to the hyper-activation of homologous recombination repair via up-regulation of RAD51 and BLM protein levels. This resulted in DNA damage disrepair, apparent by the increased frequencies of both spontaneous and chemically induced structural chromosomal aberrations and sister chromatid exchanges.Conclusions/SignificanceTogether, our data suggest that the effects of WRN silencing on cell proliferation and genomic instability are modulated probably by other genetic factors, including p53, which might play a role in the carcinogenesis induced by WRN deficiency.

Highlights

  • Werner syndrome helicase (WRN), the protein defective in Werner syndrome (WS) patients [1], belongs to the RecQ family of helicases, which are conserved from Escherichia coli to humans [2]

  • As the mechanism of how WRN mutations lead to cancer in WS patients is still not entirely understood, researchers continue to pursue a better understanding of how these cancers evolve

  • An in vivo study reported that the loss of WRN in p53 null background mice led to rapid tumorigenesis [20], this is the first time to our knowledge that the silencing of WRN has been shown to promote cell growth in vitro

Read more

Summary

Introduction

Werner syndrome helicase (WRN), the protein defective in Werner syndrome (WS) patients [1], belongs to the RecQ family of helicases, which are conserved from Escherichia coli to humans [2]. The polymorphisms of WRN gene is associated with increased risks of cancer development, including but not limit to breast, gastric adenocarcinoma and bone and soft tissue sarcomas [9,10,11,12]. Previous studies reported that WRN silencing in combination with deficiency in other genes led to significantly accelerated cellular proliferation and tumorigenesis. The aim of the present study was to examine the effects of silencing WRN in p53 deficient HL60 and p53 wild-type TK6 hematopoietic cells, in order to further the understanding of WRN-associated tumorigenesis

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.